The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugs.

Journal: The Journal of antimicrobial chemotherapy

Publication Year: 

Authors & Co-authors:  Wijk Marie M Gausi Kamunkhwala K Malatesta Samantha S Weber Sarah E SE Court Richard R Myers Bronwyn B Carney Tara T Parry Charles D H CDH Horsburgh C Robert CR White Laura F LF

Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM].

Journal: Wellcome open research

Publication Year: 

Authors & Co-authors:  Davis Angharad G AG Wasserman Sean S Maxebengula Mpumi M Stek Cari C Bremer Marise M Daroowala Remy R Aziz Saalikha S Goliath Rene R Stegmann Stephani S Koekemoer Sonya S

Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis.

Journal: Antimicrobial agents and chemotherapy

Publication Year: 2022

Authors & Co-authors:  van der Laan Louvina E LE Garcia-Prats Anthony J AJ Schaaf H Simon HS Chirehwa Maxwell M Winckler Jana L JL Mao Jun J Draper Heather R HR Wiesner Lubbe L Norman Jennifer J McIlleron Helen H

Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population.

Journal: The Journal of antimicrobial chemotherapy

Publication Year: 2022

Authors & Co-authors:  Griesel Rulan R Sinxadi Phumla P Kawuma Aida A Joska John J Sokhela Simiso S Akpomiemie Godspower G Venter Francois F Denti Paolo P Haas David W DW Maartens Gary G